New trial aims to slash COVID-19 deaths and ventilator use
NCT ID NCT04488081
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests several experimental treatments at once in critically ill COVID-19 patients who need high-flow oxygen or a ventilator. The goal is to quickly find which treatments can reduce deaths and shorten the time patients need breathing support. About 1,500 adults in the hospital are participating.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Corewell Health
Grand Rapids, Michigan, 49503, United States
-
DHR Health
Edinburg, Texas, 78539, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Georgetown University
Washington D.C., District of Columbia, 20007, United States
-
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663, United States
-
Kaiser LAMC
Los Angeles, California, 90027, United States
-
Kalispell Regional Medical Center
Kalispell, Montana, 59901, United States
-
Lankenau Medical Center (Mainline Health)
Wynnewood, Pennsylvania, 19096, United States
-
Logan Health Medical Center
Kalispell, Montana, 59901, United States
-
Long Beach Memorial Medical Center
Long Beach, California, 90806, United States
-
Main Line Health - Lankenau Medical Center
Wynnewood, Pennsylvania, 19096, United States
-
Mercy Hospital Springfield
Springfield, Missouri, 65804, United States
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Sanford Health
Souix Falls, South Dakota, 57109, United States
-
Stamford Health
Stamford, Connecticut, 06904, United States
-
UC Davis Medical Center
Davis, California, 95817, United States
-
UC Irvine Medical Center
Irvine, California, 92868, United States
-
University Hospital Cleveland Medical Center
Cleveland, Ohio, 44106, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
-
University of California San Francisco (UCSF)
San Francisco, California, 94115, United States
-
University of Colorado
Aurora, Colorado, 80045, United States
-
University of Florida
Gainesville, Florida, 32608, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
University of Miami
Coral Gables, Florida, 33124, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Pennsylvania (U Penn)
Philadelphia, Pennsylvania, 19104, United States
-
University of Rochester Medical Center
Rochester, New York, 14642, United States
-
University of Southern California
Los Angeles, California, 90033, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Virtua Mount Holly Hospital
Mount Holly, New Jersey, 08060, United States
-
Virtua Voorhees Hospital
Voorhees Township, New Jersey, 08043, United States
-
WVU Medicine
Morgantown, West Virginia, 26506, United States
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
-
Yale Cancer Center
New Haven, Connecticut, 06510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?